DiseaseID 3825
暴发性紫癜
disease
NCI2016_NICHD_1602D:Excessive activation of the body's coagulation system resulting in systemic microvascular thrombi formation.|NCI2016_FDA_1602D:A disorder characterized by reduction in the elements involved in blood c
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Disease: 1Symptom: 9Target: 12Links: 21
Arranging relationship network...
Record Fields
Scalar fields from the final disease record.
- Disease Id
- 3825
- Core Entity Id
- 60079
- Source Entity Count
- 1
- Preferred Name
- Purpura Fulminans
- Name Cn
- 暴发性紫癜
- Name Pinyin
- Bao Fa Xing Zi Dian
- Name En
- Purpura Fulminans
- Name Latin
- Bilingual Status
- complete
- Disease Type
- disease
- Umls Disease Type
- Disease or Syndrome
- Disgenet Type
- disease
- Mesh Class
- Hemic and Lymphatic DiseasesHemic and Lymphatic Diseases; Pathological Conditions, Signs and Symptoms
- Do Class
- disease of anatomical entity
- Hpo Class
- Abnormality of blood and blood-forming tissues
- Mesh Class Name
- Hemic and Lymphatic DiseasesPathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
- Hpo Class Name
- Abnormality of blood and blood-forming tissues
- Do Class Name
- disease of anatomical entity
- Disease Definition
- NCI2016_NICHD_1602D:Excessive activation of the body's coagulation system resulting in systemic microvascular thrombi formation.|NCI2016_FDA_1602D:A disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels.|NCI2016_CTCAE_1602D:A disorder characterized by systemic pathological activation of blood clotting mechanisms which results in clot formation throughout the body. There is an increase in the risk of hemorrhage as the body is depleted of platelets and coagulation factors.|NCI2016_02D:A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.|MSH2017_2016_08_12:A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.|HPO2016_07_04:Disseminated intravascular coagulation is characterized by the widespread activation of coagulation, which results in the intravascular formation of fibrin and ultimately thrombotic occlusion of small and midsize vessels. [HPO:probinson, pmid:10451465, pmid:11816725]|CSP2006:disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels; the activation of the clotting mechanism may arise from any of a number of disorders; in the late stages, it is marked by profuse hemorrhaging.|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding
- Version
- v2
- Suppressed
- No
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Purpura Fulminans
Role
preferred
Name
Disseminated Intravascular Coagulation
Role
preferred
Name
Disseminated Intravascular Coagulation [Defibrination Syndrome]
Role
alias
Cross References
Trusted external identifiers retained for this final record.
Hpo
HP:0005521
Herb
HBDIS000810HBDIS003343
Me Sh
D004211D055665
Umls
C0012739
Icd10
D65
Sym Map
SMDE07994
Do Class
DOID:7
Dis Ge Net
C0012739C0085650
Umls Sty
T047
Hpo Class
HP:0001871
Me Sh Class
C15C23
Tcmbank Disease
1288033413914
Itcmdb Generated
ITX-DISEASE-112A0D6D58F1
Attributes
Merged source attributes and domain-specific metadata.
Version
v2
Suppress
0
Do Class Name
disease of anatomical entity
Disease Type
disease
Hpo Class Name
Abnormality of blood and blood-forming tissues
Do Disease Class
disease of anatomical entity
Hpo Disease Class
Abnormality of blood and blood-forming tissues
Umls Disease Type
Disease or Syndrome
Disease Definition
NCI2016_NICHD_1602D:Excessive activation of the body's coagulation system resulting in systemic microvascular thrombi formation.|NCI2016_FDA_1602D:A disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels.|NCI2016_CTCAE_1602D:A disorder characterized by systemic pathological activation of blood clotting mechanisms which results in clot formation throughout the body. There is an increase in the risk of hemorrhage as the body is depleted of platelets and coagulation factors.|NCI2016_02D:A pathological process where the blood starts to coagulate throughout the whole body. This depletes the body of its platelets and coagulation factors, and there is an increased risk of hemorrhage.|MSH2017_2016_08_12:A disorder characterized by procoagulant substances entering the general circulation causing a systemic thrombotic process. The activation of the clotting mechanism may arise from any of a number of disorders. A majority of the patients manifest skin lesions, sometimes leading to PURPURA FULMINANS.|HPO2016_07_04:Disseminated intravascular coagulation is characterized by the widespread activation of coagulation, which results in the intravascular formation of fibrin and ultimately thrombotic occlusion of small and midsize vessels. [HPO:probinson, pmid:10451465, pmid:11816725]|CSP2006:disorder characterized by reduction in the elements involved in blood coagulation due to their utilization in widespread blood clotting within the vessels; the activation of the clotting mechanism may arise from any of a number of disorders; in the late stages, it is marked by profuse hemorrhaging.|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding|CHV2011_02:a disease where the blood clots throughout the body and increases the risk of bleeding
Me Sh Disease Class
Hemic and Lymphatic DiseasesHemic and Lymphatic Diseases; Pathological Conditions, Signs and Symptoms
Dis Ge Net Disease Type
disease
Disease Class Name Me Sh
Hemic and Lymphatic DiseasesPathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
Umls Semantic Type Name
Disease or Syndrome